LOGIN  |  REGISTER
Viking Therapeutics
Assertio

Owens & Minor to Participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference

March 01, 2023 | Last Trade: US$8.87 0.21 2.42

RICHMOND, Va. / Mar 01, 2023 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) announced today that executive leadership will participate in a fireside chat at the upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference. The discussion will take place on Thursday, March 2 at 8:45 a.m. Eastern Time.

Please visit the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-presentations/ at least ten minutes in advance to register for the live webcast of the discussion. A replay of the webcast can be accessed following the presentation at the link provided above.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company integrating product manufacturing and delivery, home health supply and perioperative services to support care through the hospital and into the home. Owens & Minor drives visibility, control and efficiency for patients, providers and healthcare professionals across the supply chain with proprietary technology and solutions, an extensive product portfolio, an Americas-based manufacturing footprint for personal protective equipment (PPE) and surgical products, as well as a robust portfolio of products and services for patients managing chronic and acute conditions in the home setting. Operating continuously since 1882 from its headquarters in Richmond, Va., Owens & Minor is a 140-year-old company powered by more than 20,000 global teammates. Learn more at https://www.owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Recursion

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page